Consumer Electronics Show CES the world premier tech show concluded in the US city of Las Vegas on Friday showcasing latest advancemen ...

The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

Stay updated on the volatile share price of Recursion, a biotech company with a maturing pipeline and potential for growth ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

The drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While ...

SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the company's growth, ...

A middle school student in Chicago made headlines by uncovering a remarkable medical breakthrough hidden in a surprising ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...

Additionally, rapid, substantial and sustained statistically significant reductions in 17-OHP, a confirmatory secondary biomarker of disease control, were achieved across doses. Treatment with ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...